Literature DB >> 8229375

Patient-oriented functional outcome after unilateral lower extremity fracture.

E J MacKenzie1, A R Burgess, M P McAndrew, M F Swiontkowski, B M Cushing, B J deLateur, G J Jurkovich, J A Morris.   

Abstract

To determine patient-perceived functional outcome after lower extremity fracture (LEF), a prospective, follow-up study of patients managed at three level I trauma centers was conducted. Patients with unilateral LEF involving the acetabulum and distally were eligible for the study. A total of 444 patients were enrolled. Of these, 363 (82%) were interviewed at 6 months postdischarge. Study patients were predominantly young (mean age 34 years), white (72%) men (71%) who had been working preinjury (78%). Their injuries resulted primarily from motor vehicle crashes (73%); 30% had more than one fracture to the same extremity. Functional status was measured using the Sickness Impact Profile (SIP), a well-validated, general health status instrument. Mean 6-month SIP scores were significantly worse (higher) than those based on preinjury activities (9.8 vs. 2.5) (p < 0.01). Overall disability levels were moderate compared with other health conditions. Analysis of the 12 subscores comprising the SIP indicated particularly high scores in ambulation (16.2 postdischarge vs. 1.1 preinjury), sleep/rest (13.1 vs. 5.1), household management (14.5 vs. 2.6), recreation (17.6 vs. 4.2), emotional well-being (9.9 vs. 2.1), and most significantly work (33.2 vs. 8.8). Of those working preinjury, only 49% had returned by 6 months. SIP scores were highest for persons with three or more fractures to the same extremity and for fracture patterns typical of high-energy forces.

Entities:  

Mesh:

Year:  1993        PMID: 8229375     DOI: 10.1097/00005131-199310000-00001

Source DB:  PubMed          Journal:  J Orthop Trauma        ISSN: 0890-5339            Impact factor:   2.512


  8 in total

1.  Proximal tibial metaphyseal fractures with severe soft tissue injury: clinical and functional results at 2 years.

Authors:  James S Starman; Renan C Castillo; Michael J Bosse; Ellen J MacKenzie
Journal:  Clin Orthop Relat Res       Date:  2009-10-28       Impact factor: 4.176

2.  Computer assisted outcomes research in orthopedics: total joint replacement.

Authors:  C Arslanian; M Bond
Journal:  J Med Syst       Date:  1999-06       Impact factor: 4.460

3.  Risk factors for complications and adverse outcomes in polytrauma patients with associated upper extremity injuries.

Authors:  Florin Allemann; Sandro Heining; Boris Zelle; Christian Probst; Hans-Christoph Pape
Journal:  Patient Saf Surg       Date:  2019-02-04

4.  Responsiveness of the EuroQol (EQ 5-D) and the SF-36 in elderly patients with displaced femoral neck fractures.

Authors:  J Tidermark; G Bergström; O Svensson; H Törnkvist; S Ponzer
Journal:  Qual Life Res       Date:  2003-12       Impact factor: 4.147

5.  Reaming Does Not Affect Functional Outcomes After Open and Closed Tibial Shaft Fractures: The Results of a Randomized Controlled Trial.

Authors:  Carol A Lin; Marc Swiontkowski; Mohit Bhandari; Stephen D Walter; Emil H Schemitsch; David Sanders; Paul Tornetta
Journal:  J Orthop Trauma       Date:  2016-03       Impact factor: 2.512

6.  Hyperbaric Oxygen in Lower Limb Trauma (HOLLT); protocol for a randomised controlled trial.

Authors:  Ian L Millar; Rosemary A McGinnes; Owen Williamson; Folke Lind; Karl-Åke Jansson; Michal Hajek; David Smart; Tiago Fernandes; Russell Miller; Paul Myles; Peter Cameron
Journal:  BMJ Open       Date:  2015-06-11       Impact factor: 2.692

7.  Functional outcomes more than 5 years following acetabulum fracture.

Authors:  Isabella M Heimke; Sahini Pothireddy; J Collin Krebs; Mary A Breslin; Heather A Vallier
Journal:  OTA Int       Date:  2022-02-28

8.  The course of health status and (health-related) quality of life following fracture of the lower extremity: a 6-month follow-up study.

Authors:  M A C Van Son; J De Vries; J A Roukema; T Gosens; M H J Verhofstad; B L Den Oudsten
Journal:  Qual Life Res       Date:  2015-11-05       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.